8-K//Current report
Celsus Therapeutics Plc. 8-K
Accession 0001144204-15-042637
$AKTXCIK 0001541157operating
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 12:37 PM ET
Size
2.0 MB
Accession
0001144204-15-042637
Documents
- 8-Kv415534_8k.htmPrimary
CURRENT REPORT
- EX-99.1v415534_ex99-1.htm
INVESTOR PRESENTATION
- GRAPHICimage_001.jpg
GRAPHIC
- GRAPHICimage_002.jpg
GRAPHIC
- GRAPHICimage_003.jpg
GRAPHIC
- GRAPHICimage_004.jpg
GRAPHIC
- GRAPHICimage_005.jpg
GRAPHIC
- GRAPHICimage_006.jpg
GRAPHIC
- GRAPHICimage_007.jpg
GRAPHIC
- GRAPHICimage_008.jpg
GRAPHIC
- GRAPHICimage_009.jpg
GRAPHIC
- GRAPHICimage_010.jpg
GRAPHIC
- GRAPHICimage_011.jpg
GRAPHIC
- GRAPHICimage_012.jpg
GRAPHIC
- GRAPHICimage_013.jpg
GRAPHIC
- GRAPHICimage_014.jpg
GRAPHIC
- GRAPHICimage_015.jpg
GRAPHIC
- GRAPHICimage_016.jpg
GRAPHIC
- GRAPHICimage_017.jpg
GRAPHIC
- GRAPHICimage_018.jpg
GRAPHIC
- GRAPHICimage_019.jpg
GRAPHIC
- GRAPHICimage_020.jpg
GRAPHIC
- GRAPHICimage_021.jpg
GRAPHIC
Issuer
Akari Therapeutics Plc
CIK 0001541157
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001541157
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 12:37 PM ET
- Size
- 2.0 MB